Cargando…
Suppression of Human Pancreatic Cancer Growth in BALB/c Nude Mice by Manumycin, a Farnesyl:protein Transferase Inhibitor
Activating mutations of Ki‐ras have been detected in most human pancreatic adenocarcinomas. Since Ras protein requires farnesylation to function, we investigated the effects of manumycin, a potent farnesyl:protein transferase inhibitor, on the growth in nude mice of a human pancreatic cancer cell li...
Autores principales: | Ito, Toshio, Kawata, Sumio, Tamura, Shinji, Igura, Takumi, Nagase, Toshihiko, Miyagawa, Jun‐ichiro, Yamazaki, Eiji, Ishiguro, Hiroshi, Matsuzawa, Yuji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921057/ https://www.ncbi.nlm.nih.gov/pubmed/8609057 http://dx.doi.org/10.1111/j.1349-7006.1996.tb03146.x |
Ejemplares similares
-
Manumycin and gliotoxin derivative KT7595 block Ras farnesylation and cell growth but do not disturb lamin farnesylation and localization in human tumour cells.
por: Nagase, T., et al.
Publicado: (1997) -
Effect of Pravastatin, a Potent 3‐Hydroxy‐3‐methylgliitaryl‐coenzyme A Reductase Inhibitor, on Survival of AH130 Hepatoma‐bearing Rats
por: Kawata, Sumio, et al.
Publicado: (1992) -
Elevated Levels of Plasma Transforming Growth Factor‐β in Patients with Hepatocellular Carcinoma
por: Shirai, Yasuhiro, et al.
Publicado: (1992) -
Modulation of c‐myc Expression by Transforming Growth Factor β1 in Human Hepatoma Cell Lines
por: Ito, Nobuyuki, et al.
Publicado: (1990) -
Use of Farnesyl Transferase Inhibitors in an Ageing Model in Drosophila
por: Brandt, Annely, et al.
Publicado: (2023)